Measles vaccine--feasibility, efficacy and complication rates in a multicentric study
Basu, R.N.
Indian Journal of Pediatrics 51(409): 139-143
1984
ISSN/ISBN: 0019-5456 PMID: 6500640 Document Number: 236767
Document emailed within 1 workday
Related Documents
Martins, C.; Garly, M-Lill.; Bale, C.; Rodrigues, A.; Benn, C.S.; Whittle, H.; Aaby, P. 2013: Measles antibody levels after vaccination with Edmonston-Zagreb and Schwarz measles vaccine at 9 months or at 9 and 18 months of age: a serological study within a randomised trial of different measles vaccines Vaccine 31(48): 5766-5771Wilson, T.S. 1971: A study of the incidence and mortality of measles and whooping cough in Glasgow from 1855, with reference to birth rates, death rates and death rates of children under one year Health Bulletin 29(4): 206-213
Talwar, G.P.; Singh, O.M.; Gupta, S.K.; Hasnain, S.E.; Pal, R.; Majumbar, S.S.; Vrati, S.; Mukhopadhay, A.; Srinivasan, J.; Deshmukh, U.; Ganga, S.; Mandokhot, A.; Gupta, A. 1997: The HSD-hCG vaccine prevents pregnancy in women: Feasibility study of a reversible safe contraceptive vaccine American Journal of Reproductive Immunology 37(2): 153-160
Fowlkes, A.; Witte, D.; Beeler, J.; Audet, S.; Garcia, P.; Curns, A.; Yang, C.; Fudzulani, R.; Broadhead, R.; Bellini, W.J.; Cutts, F.; Helfand, R.F. 2011: Persistence of vaccine-induced measles antibody beyond age 12 months: a comparison of response to one and two doses of Edmonston-Zagreb measles vaccine among HIV-infected and uninfected children in Malawi Journal of Infectious Diseases 204(Suppl 1): S149-S157
Colomer Pache, M.; Arnedo Pena, A. 1988: Study of a measles epidemic in Gátova (Castellón) and the efficacy of measles vaccination Medicina Clinica 91(17): 649-652
Puri, A.; Gupta, V.K.; Chakravarti, A.; Mehra, M. 2002: Measles vaccine efficacy evaluated by case reference technique Indian Pediatrics 39(6): 556-560
Tikhonova, N.T.; Khrometskaia, T.M.; Livanova, L.V.; Poliakova, T.A.; Azarova, S.A. 1978: Several indices of humoral anti-measles immunity in children, previously immunized with live measles vaccine, who have developed measles Voprosy Virusologii 3: 322-327
Hinman, A.R.; Brandling-Bennet, A.D.; Bernier, R.H.; Kirby, C.D.; Eddins, D.L. 1980: Current features of measles in the United States: feasibility of measles elimination Epidemiologic Reviews 2: 153-170
Botticelli, A.R.; Marandola, P.; Jallous, H.; Vicini, D.; Migaldi, M.; Speroni, A.; Mirando, P. 1995: Quantitative and qualitative AgNORs rates of prostate cancer on needle core biopsies: a multicentric study Pathologica 87(6): 624-630
Makino, S.; Sasaki, K.; Nakamura, N.; Nakagawa, M.; Nakajima, S. 1974: Studies on the modification of the live AIK measles vaccine. II. Development and evaluation of the live AIK-C measles vaccine Kitasato Archives of Experimental Medicine 47(1-2): 13-21
Techasena, W.; Sriprasert, P.; Pattamadilok, S.; Wongwacharapipoon, P. 2007: Measles antibody in mothers and infants 0-2 years and response to measles vaccine at the age of 9 and 18 months Journal of the Medical Association of Thailand 90(1): 106-112
Modlin, J.F.; Jabbour, J.T.; Witte, J.J.; Halsey, N.A. 1977: Epidemiologic studies of measles, measles vaccine, and subacute sclerosing panencephalitis Pediatrics 59(4): 505-512
Kanbur, N.Oksüz.; Derman, O.; Kutluk, T. 2005: Measles seroprevalence of an adolescent population vaccinated with a single dose of measles vaccine before their first birthday International Journal of Adolescent Medicine and Health 17(4): 337-341
Markowitz, L.E.; Nieburg, P. 1991: The burden of acute respiratory infection due to measles in developing countries and the potential impact of measles vaccine Reviews of Infectious Diseases 13(Suppl): S555-S561
Robinson, M.O.; Halverson, P. 1991: Port-A-Cath: a study of complication rates South Dakota Journal of Medicine 44(7): 187-190
Hutchins, S.S.; Escolan, J.; Markowitz, L.E.; Hawkins, C.; Kimbler, A.; Morgan, R.A.; Preblud, S.R.; Orenstein, W.A. 1989: Measles outbreak among unvaccinated preschool-aged children: opportunities missed by health care providers to administer measles vaccine Pediatrics 83(3): 369-374
Miura, S. 1968: Effects of the combined administration of a triple vaccine of pertussis, diphtheria and tetanus and virus vaccine (live polio vaccine or inactivated measles vaccine) on immunity to pertussis, diphtheria and tetanus. 1. Results of the initial immunization Nihon Shonika Gakkai Zasshi. Acta Paediatrica Japonica 72(6): 767-781
Schmitt-Grohé, S.; Stehr, K.; Cherry, J.D.; Heininger, U.; Uberall, M.A.; Laussucq, S.; Eckhardt, T. 1997: Minor adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine. The Pertussis Vaccine Study Group Developments in Biological Standardization 89: 113-118
Bahl, R.; Kumar, R.; Bhandari, N.; Kant, S.; Srivastava, R.; Bhan, M.K. 1999: Vitamin a administered with measles vaccine to nine-month-old infants does not reduce vaccine immunogenicity Journal of Nutrition 129(8): 1569-1573
Piraccini, B.; Starace, M.; Alessandrini, A.; Guarrera, M.; Fiorucci, M.C.; Lorenzi, S. 2011: Efficacy and tolerability of 5% minoxidil solution (Carexidil®) in male and female androgenetic alopecia: a 6-month open multicentric study Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 146(6 Suppl 1: 1-8